Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled time : 12:30 save search
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Published: 2024-03-18 (Crawled : 12:30) - prnewswire.com
CTXR | $0.8 -1.99% -2.02% 6.3M
|
Health Technology
|
| O: -2.23%
H: 11.11%
C: 0.03%
fda t-cell resubmission treatment pharmaceuticals
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
Published: 2024-03-07 (Crawled : 12:30) - globenewswire.com
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
|
| O: 8.33%
H: 4.2%
C: -2.8%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -9.21%
mb-101 publication trial
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
Published: 2024-03-07 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 0.79%
H: 0.78%
C: 0.78%
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
|
| O: 8.33%
H: 4.2%
C: -2.8%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -9.21%
tumors cell city trial therapy
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
Published: 2023-12-05 (Crawled : 12:30) - prnewswire.com
GDTC | $2.03 -1.93% -1.97% 3.3K
|
|
| O: 0.82%
H: 0.82%
C: -3.27%
cell research technology therapeutics
Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations
Published: 2023-11-06 (Crawled : 12:30) - prnewswire.com
ATNM | $6.67 -8.0% 1.2% 420K
|
Health Technology
|
| O: 0.63%
H: 4.38%
C: -5.01%
cell tumor preclinical immunotherapy potential
Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress
Published: 2023-10-13 (Crawled : 12:30) - prnewswire.com
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 3.39%
H: 1.63%
C: -0.37%
t-cell congress presentation
GenFleet Starts Phase Ib/II Trial of GFH009 (Highly Selective CDK9 Inhibitor) Treating Patients with Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL)
Published: 2023-10-10 (Crawled : 12:30) - biospace.com/
SLS | $1.505 6.74% 6.31% 1.6M
|
Health Technology
|
| O: 0.0%
H: 10.48%
C: -0.7%
gfh009 t-cell lymphomas trial
SQZ Biotechnologies Announces Publication of Comprehensive Preclinical Research on SQZ® APC’s Ability to Overcome Fundamental Biological Barrier to Effective and Efficient Killer T Cell Activation
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: 19.91%
H: 0.0%
C: -1.85%
sqz research cel preclinical biotech iot t-cell pre-clinical
Intellia Therapeutics and Kyverna Therapeutics Announce Collaboration to Develop Next-Generation Allogeneic T-Cell Therapy for Autoimmune Diseases
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: -1.3%
H: 1.04%
C: -7.77%
therapeutics disease cel intel therapy collaboration t-cell
Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 5.33%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
tnx-2100 als clearance skin cel sars-cov-2 test t-cell
Achilles Therapeutics Presents Positive Data at ESMO I-O Congress 2021 on High-Dose Manufacturing Process for Precision T Cell Therapies Targeting Clonal Neoantigens
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
ACHL | $0.795 -2.39% -2.45% 190K
|
Manufacturing
|
| O: 5.43%
H: 6.09%
C: -5.15%
therapeutics positive t-cell
Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
GLSI | $13.12 0.54% 0.53% 42K
|
Health Technology
|
| O: 4.11%
H: 0.9%
C: -12.42%
technology trial presentation potential platform t-cell
Role of B Cells Induced by IMV’s Lead Compound in Patients with Ovarian Cancer to be Showcased at the ESMO-IO Congress
Published: 2021-12-02 (Crawled : 12:30) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: -2.17%
H: 11.11%
C: 10.37%
ovarian cancer cancer t-cell
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
Published: 2021-12-02 (Crawled : 12:30) - globenewswire.com
TCRX 1 d | $6.9 2.22% 2.17% 250K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $58.69 1.28% 0.36% 960K
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan therapy t-cell
SQZ Biotechnologies Lead Cell Therapy Candidate Generated Monotherapy Clinical Response Correlated with Substantial CD8 T Cell Tumor Infiltration in HPV+ Solid Tumor at Highest Dose
Published: 2021-12-02 (Crawled : 12:30) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: -10.45%
H: 5.31%
C: -5.72%
hpv therapy biotech iot t-cell
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.